Pharmaceuticals, Biotechnology and Life Sciences
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™)…
5 of the top 7 CROs join Vault CDMS CRO partner program to speed the deployment of high-quality clinical trials…
Multichannel patient portal will help clinical research sites conduct virtual patient visits eSource capability will enable paperless clinical trials BARCELONA,…
New application will connect sponsors and sites for better collaboration and faster study execution Veeva Clinical Network will bring together…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#COVID19—Centivax Inc, the therapeutics spin-out of Contract Research Organization Distributed Bio Inc, announced a significant advance…
Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx, said that the company will release topline data from the LUMINA-2 study of CCX140.
Covid-19 has caused great interruption to pharmaceutical trials, as most resources have shifted to finding a vaccine and many ongoing trials have been disrupted, according to a report by Wakefield Research, an independent provider of market research and market intelligence.
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of…
Moderna said that after two doses all participants evaluated to date across the 25 µg and 100 µg dose cohorts…